Need a specific person's email?
Browse CLINUVEL PHARMACEUTICALS LTD's employee directory (about 80 employees) and reveal verified emails free.
CLINUVEL PHARMACEUTICALS LTD's most common email format is First.Last@clinuvel.com (ex. John.Doe@clinuvel.com), used for 98% of clinuvel.com addresses. CLINUVEL PHARMACEUTICALS LTD uses 3 email patterns.
| Format | Example | Share of clinuvel.com |
|---|---|---|
| First.Last@clinuvel.comMost common | John.Doe@clinuvel.com | |
| FirstLast@clinuvel.com | JohnDoe@clinuvel.com | |
| FL@clinuvel.com | JD@clinuvel.com |
Browse CLINUVEL PHARMACEUTICALS LTD's employee directory (about 80 employees) and reveal verified emails free.
Biotechnology ResearchVictoria, Australia51-200 Employees
CLINUVEL Pharmaceuticals is a global biotechnology company focused on photomedicine, researching how light interacts with human biology to develop treatments for genetic, metabolic, and life-threatening disorders, as well as broader healthcare solutions. Its work centers on delivering systemic photoprotection and DNA repair therapies for patients with unmet medical needs across diverse populations. The lead therapy, SCENESSE (afamelanotide 16 mg), has regulatory approvals in Europe in 2014 and in the United States in 2019 for preventing phototoxic reactions in adults with erythropoietic protoporphyria. Headquartered in Melbourne, Victoria, the company operates across Europe, Singapore, and the United States. In 2025 it expanded its Singapore-based VALLAURIX research, development and innovation centre, signaling a move to establish a global hub for advanced peptide-based therapies.
Most common format
First.Last@clinuvel.com
Example: John.Doe@clinuvel.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.